首页> 外文期刊>Clinical and diagnostic laboratory immunology >T- and B-Cell Immune Responses of Patients Who Had Undergone Colectomies to Oral Administration of Salmonella enterica Serovar Typhi Ty21a Vaccine
【24h】

T- and B-Cell Immune Responses of Patients Who Had Undergone Colectomies to Oral Administration of Salmonella enterica Serovar Typhi Ty21a Vaccine

机译:接受过肠壁切除术的患者对肠道沙门氏菌血清型伤寒Typhi Ty21a疫苗的T细胞和B细胞免疫反应

获取原文
           

摘要

The capacity of an oral live attenuated Salmonella enterica serovar Typhi Ty21a vaccine to induce immune responses in patients who had undergone colectomies because of ulcerative colitis was evaluated, and these responses were compared with those of healthy volunteers. Purified CD4+ and CD8+ T cells from peripheral blood were stimulated in vitro by using the heat-killed Ty21a vaccine strain, and the proliferation and gamma interferon (IFN-γ) production were measured before and 7 or 8 days after vaccination. Salmonella-specific immunoglobulin A (IgA) and IgG antibody responses in serum along with IgA antibody responses in ileostomy fluids from the patients who had undergone colectomies were also evaluated. Three doses of vaccine given 2 days apart failed to induce proliferative T-cell responses in all the six patients who had undergone colectomies, and increases in IFN-γ production were found only among the CD8+ cells from three of the patients. In contrast, both proliferative responses and increased IFN-γ production were observed among CD4+ and CD8+ T cells from 3 and 6 of 10 healthy volunteers, respectively. Salmonella-specific IgA and/or IgG antibody responses in serum were observed for five (56%) of nine patients who had undergone colectomies and in 15 (88%) of 17 healthy volunteers. In ileostomy fluids, significant anti-Salmonella IgA antibody titer increases were detected in six (67%) of nine patients who had undergone colectomies. The impaired T- and B-cell immune responses found after vaccination in the circulation of patients who have undergone colectomies may be explained by a diminished colonization of the Ty21a vaccine strain due to the lack of a terminal ileum and colon.
机译:评价了口服减毒的 Salmonella enterica 血清型鼠伤寒Typhi Ty21a疫苗在因溃疡性结肠炎而接受肠壁切除术的患者中诱导免疫反应的能力,并将这些反应与健康志愿者进行了比较。用热灭活的Ty21a疫苗株体外刺激外周血中纯化的CD4 + 和CD8 + T细胞,并刺激其增殖和γ-干扰素(IFN-γ)。在疫苗接种之前和之后的7或8天测量产量。还评估了沙门氏菌特异性免疫球蛋白A(IgA)和血清中的IgG抗体反应,以及接受鞘膜切除术的患者回肠造口液中的IgA抗体反应。间隔2天服用三剂疫苗未能在所有接受鞘膜切除术的6例患者中诱导增殖性T细胞应答,并且仅在3个CD8 + 细胞中发现IFN-γ产生增加的病人。相比之下,分别在10名健康志愿者中的3名和6名CD4 + 和CD8 + T细胞中观察到增殖反应和IFN-γ产生增加。在9名接受了Colectomies的患者中有5名(56%)和17名健康志愿者中的15名(88%)观察到血清中的沙门氏菌特异性IgA和/或IgG抗体反应。在回肠造口液中,在接受结肠电切术的9例患者中,有6例(67%)检测到抗沙门氏菌IgA抗体效价显着增加。接受了colectomies的患者的循环中接种疫苗后发现的T细胞和B细胞免疫反应受损,可能是由于缺乏末端回肠和结肠而导致Ty21a疫苗株的定殖减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号